Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow ...
Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...
Autonomous continuous processing transforms API manufacturing with inline NMR, AI-driven control, and real-time optimization ...
The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.
NEWARK, Del., March 23, 2026--(BUSINESS WIRE)--Wilmington PharmaTech ("Wilmington"), a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex custom ...
EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.
Peak Technology Unveils APEX: A Product Development & Realization Platform Designed to Provide Deep Tech OEMs with Rapid Prototyping, New Product Introduction, and High Volume Manufacturing Solutions ...
India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...
Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management and a leading global provider of automated, process-driven medical device manufacturing solutions, has ...
Modern manufacturing is undergoing a rapid transformation, driven by the need for greater efficiency, precision, and scalability. At the heart of this shift is automated manufacturing technology, ...
Himachal Pradesh has initiated a Rs 250-crore project to establish a bulk drug park in Una district, aiming to transform the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results